熊去氧胆酸
胆汁淤积
医学
肝内胆管
原发性胆汁性肝硬化
自身免疫
胆管
发病机制
丙酮酸脱氢酶复合物
原发性硬化性胆管炎
免疫系统
免疫学
内科学
胃肠病学
疾病
生物
酶
生物化学
作者
M Y Zhang,Jingmin Zhao,Hui Xie,Qifeng Liang,Zhengxing Zou,Yiwu Sun
标识
DOI:10.3760/cma.j.cn501113-20210430-00213
摘要
Primary biliary cholangitis (PBC) is an autoimmune liver disease, mainly characterized by chronic progressive cholestasis. The root cause of PBC is the loss of immune tolerance to autoantigen E2 subunit of pyruvate dehydrogenase (PDC-E2). The unique immunobiological characteristics of intrahepatic bile duct epithelial cells make it an active participant in the pathogenesis of PBC. In recent years, the detection rate of PBC has been increasing year by year, but the clinical situation of ursodeoxycholic acid monotherapy has not changed. Therefore, an in-depth understanding of the immune pathogenesis of PBC will help clinicians better prevent and treat diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI